Filing Flows › Rockwell Medical (RMTI) › Q3 2025
Rockwell Medical (RMTI) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 12, 2025
Rockwell Medical (RMTI) reported revenue of $15.9M for the third quarter 2025 (Q3 2025), -44% from a year earlier and -0.9% from the quarter before. Operating margin was -9.9%, net loss $1.8M (11.0% of revenue).
Rockwell Medical, Q3 2025: revenue $15.9M (-44% year over year), operating margin -9.9%, net loss $1.8M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.9M | -0.9% | -44% |
| Operating profit | −$1.6M | — | — |
| Net earnings | −$1.8M | — | — |
| Operating cash flow | −$1.3M | -171% | — |
What changed
Revenue was $15.9M in Q3 2025, down 44% year over year and down 1% from the previous quarter.
Gross margin was 14.3%, down 7.8 points from a year earlier. Operating costs exceeded revenue by $1.6M, an operating margin of -9.9%. Operating expenses fell 10% while revenue fell 44%. The quarter ended with a net loss of $1.8M, wider than the previous quarter's $1.5M loss.
Operating cash flow was −$1.3M. Non-cash charges added back $544K of depreciation and amortization and $532K of share-based compensation. Working capital and other items used $630K. Capital expenditures of $229K exceeded it, leaving free cash flow of −$1.5M.
Questions
What was Rockwell Medical's revenue in the third quarter 2025?
Rockwell Medical (RMTI) reported revenue of $15.9M for the third quarter 2025 (Q3 2025), -44% from a year earlier and -0.9% from the quarter before.
Was Rockwell Medical profitable in the third quarter 2025?
Operating loss was $1.6M (-9.9% of revenue) and net loss $1.8M.
Source: Rockwell Medical 10-Q on SEC EDGAR.